Climb Bio Inc.
CLYM | NASDAQ
$10.24
-$0.09 (-0.87%)
At close: Oct 30, 2026, 3:59 PM ET
$10.15
-$0.09 (-0.88%)
Pre-market:
Nov 2, 2026, 7:01 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 68K | 106K | 68K | 38K | 38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -68K | -106K | -68K | -38K | -38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -64.76M | -60.08M | -67.88M | -59.5M | -56.34M | -102.03M | -82.02M | -76.23M | -69.5M | -19.84M | -40.28M | -44.71M | -48.45M | -55.44M | -45.14M | -46.28M | -46.92M | -41.93M | -35.67M | -40.08M | -32.95M | -25.85M |
Interest Income | 3.68M | 4M | 6.29M | 6.98M | 6.98M | 4.81M | 3.86M | 2.69M | 3.95M | 3.95M | 3.51M | 2.16M | 1.28M | 1.28M | 383K | 383K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -57.62M | -52.79M | -59.85M | -50.75M | -46.76M | -92.98M | -73.9M | -69.12M | -64.2M | -14.53M | -35.12M | -39.24M | -44.95M | -54.33M | -45.24M | -48.03M | -47.96M | -42.08M | -47.48M | -51.8M | -44.44M | -37.35M |
Net Income | -57.62M | -52.79M | -59.85M | -50.75M | -46.76M | -92.98M | -73.9M | -69.12M | -64.2M | -14.53M | -35.12M | -39.24M | -44.95M | -54.33M | -45.24M | -48.03M | -47.96M | -42.08M | -47.48M | -51.8M | -44.44M | -37.35M |
Selling & General & Admin | 22.83M | 21.29M | 21.14M | 20.56M | 20.24M | 19.8M | 16.03M | 13.07M | 9.7M | 9.06M | 24.86M | 27.5M | 29.86M | 31.77M | 18.92M | 18.12M | 17.02M | 15M | 12.35M | 10.06M | 6.98M | 4.32M |
Research & Development | 41.86M | 38.72M | 46.71M | 38.93M | 36.1M | 82.23M | 66M | 63.16M | 59.8M | 10.78M | 15.41M | 17.21M | 18.59M | 23.67M | 26.21M | 28.17M | 29.9M | 26.92M | 23.32M | 20.86M | 16.81M | 12.38M |
Other Expenses | n/a | -38K | -38K | -38K | -38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.16M | 9.16M | 9.16M |
Operating Expenses | 64.69M | 59.97M | 67.82M | 59.46M | 56.3M | 102.03M | 82.02M | 76.23M | 69.5M | 19.84M | 40.28M | 44.71M | 48.45M | 55.44M | 45.14M | 46.28M | 46.92M | 41.93M | 35.67M | 40.08M | 32.95M | 25.85M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 64.76M | 60.08M | 67.88M | 59.5M | 56.34M | 102.03M | 82.02M | 76.23M | 69.5M | 19.84M | 40.28M | 44.71M | 48.45M | 55.44M | 45.14M | 46.28M | 46.92M | 41.93M | 35.67M | 40.08M | 32.95M | 25.85M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 76.15M | 68.21M | 67.37M | 67.83M | 67.59M | 67.46M | 64.74M | 67.01M | 30.35M | 27.64M | 27.31M | 27.07M | 26.84M | 26.54M | 26.37M | 26.34M | 26.3M | 26.24M | 26.23M | 15.59M | 23.46M | 11.66M |
Shares Outstanding (Diluted) | 76.15M | 68.21M | 67.37M | 68M | 67.59M | 67.46M | 64.74M | 67.01M | 30.35M | 27.64M | 27.31M | 27.07M | 26.84M | 26.54M | 26.37M | 26.34M | 26.3M | 26.24M | 26.23M | 15.59M | 23.46M | 11.66M |
EPS (Basic) | -0.83 | -0.78 | -0.89 | -0.76 | -0.70 | -2.38 | -2.13 | -2.13 | -2.15 | -0.53 | -1.31 | -1.47 | -1.69 | -2.06 | -1.72 | -1.83 | -2.16 | -2.06 | -3.25 | -4.12 | -3.65 | -3.37 |
EPS (Diluted) | -0.83 | -0.78 | -0.89 | -0.76 | -0.70 | -2.38 | -2.13 | -2.13 | -2.15 | -0.53 | -1.31 | -1.47 | -1.69 | -2.06 | -1.72 | -1.83 | -2.16 | -2.06 | -3.25 | -4.12 | -3.65 | -3.37 |
EBITDA | -59.36M | -52.66M | -59.75M | -50.68M | -46.72M | -92.98M | -73.9M | -69.12M | -64.2M | -14.53M | -35.12M | -39.24M | -44.95M | -54.33M | -45.24M | -48.03M | -47.96M | -42.08M | -35.76M | -31.16M | -23.81M | -16.7M |
EBIT | -59.49M | -52.79M | -59.85M | -50.75M | -46.76M | -92.98M | -73.9M | -69.12M | -64.2M | -14.53M | -35.12M | -39.24M | -44.95M | -54.33M | -45.24M | -48.03M | -47.96M | -42.08M | -35.76M | -31.16M | -23.81M | -16.7M |
Depreciation & Amortization | 130K | 135K | 97K | 67K | 38K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CLYM